NOV 11, 2015 10:30 AM PST

Agilent StreamSelect LC/MS System: Future solutions for the high throughput lab

Speaker
  • Application Scientist, Agilent Technologies
    Biography
      Kevin McCann is an application scientist at Agilent Technologies in Santa Clara, California where he focus on LC/MS workflows and solutions. He has contributed to the development of many analytical methods and customer collaborations as well as enabling technologies, such as the Agilent StreamSelect LC/MS system and MassHunter Examiner. Prior to his work at Agilent, Kevin was the laboratory manager of the biochemical genetics laboratory at Mount Sinai Hospital in New York where he also developed LC/MS methods for the analysis of warfarin, tamoxifen, acylcarnitine profiles, and amino acid profiles.

    Abstract

    Liquid chromatography triple quadrupole mass spectrometry (LC/MS/MS) is ideally suited for the direct and rapid analysis of prepared biological samples. While analysis times can be shortened through appropriate LC method choices, a user is often interested in only a portion of the total data collected by an LC/MS system. Typically, there is time during each chromatographic separation where no compounds of interest are being analyzed by the mass spectrometer, leaving the instrument under-utilized. The Agilent StreamSelect LC/MS Solution eliminates instrument idle time and maximizes productivity using highly integrated, intuitive software that allows users to run parallel HPLC streams in a staggered fashion. This system can provide up to four times the throughput of a traditional LC/MS system while remaining compatible with existing LC/MS methods. Through this presentation, attendees will learn about the various workflows supported by the Agilent StreamSelect LC/MS system and the quantitative performance achieved with this instrument.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    Loading Comments...
    Show Resources
    Attendees
    • See more